相关实验视频

Updated: Jul 9, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

生物信息学分析和实验验证表明,CDC20过度表达促进了膀癌的进展和潜在的潜在机制

Yuan Liu¹, Shao-Hui Zou¹, Xin Gao^2,3

¹Clinical Laboratory, Hunan University of Medicine General Hospital, Huaihua, Hunan, 418000, China.

Genes & genomics

|March 4, 2024

概括

膀癌中高的CDC20表达与预后不佳和治疗耐药性相关. 降低CDC20的调节抑制了瘤细胞的增殖和入侵,这表明它是潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

膀癌是一种常见的恶性瘤,细胞循环调节者的作用尚不清楚.
CDC20是一个关键的细胞循环调节剂,与瘤细胞增殖有关.

研究的目的:

在膀癌中分析CDC20表达.
研究CDC20在瘤进展,治疗反应和预后方面的作用.
探索CDC20在膀癌细胞生长中的机制.

主要方法:

在膀癌中对CDC20表达的生物信息分析.
评估CDC20对化疗/放射治疗敏感性和预后的影响.
调查CDC20甲基化水平及其与预后的关联.
在膀癌细胞系 (5637,T24) 中通过lentiviral transfection降低CDC20的调节.
进行细胞增殖,入侵,细胞亡和细胞循环测试.

主要成果:

在膀癌中,CDC20的高度表达,与预后不佳和高诊断潜力 (AUC>0.9) 相相关.
瘤中CDC20甲基化的降低与更差的预后和增加的突变负担有关.
高的CDC20表达可能会对化疗和放射治疗产生耐药性,可能会影响免疫细胞透.
CDC20下调抑制膀癌细胞的扩散和入侵,导致G1阶段停止.

结论:

异常高的CDC20表达驱动膀癌的进展和不良预后.
CDC20代表了膀癌的潜在治疗点.

关键词:

膀癌是一种癌症.美国疾病预防控制中心20 CDC20 细胞循环的细胞周期预测预后预测预测核武器的扩散治疗目标治疗目标

更多相关视频

Cell-Free DNA Integrity Analysis in Urine Samples

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...